In a significant development aimed at bolstering India's medical technology (MedTech) sector, the Anusandhan National Research Foundation (ANRF), in conjunction with the Indian Council of Medical Research (ICMR) and the Gates Foundation...
Recently published data from the FLUNITY-HD Study in The Lancet illustrates that Efluelda provided significantly more protection against hospitalizations than standard-dose influenza vaccines in adults aged 65 and older...
Indegene today unveiled its ambitious expansion of the Consulting Practice, reaffirming its ongoing commitment to enable life sciences organizations to navigate value and risk in large transformation efforts, in a complex, technology-driven world...
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ankit Gupta, President of ASPA, discusses how serialization and digital authentication are driving a paradigm shift in the pharmaceutical industry
Biocon Biologics Ltd. (BBL), a leading global biosimilars company and subsidiary of Biocon Ltd., announced today the extension of its strategic collaboration with Civica, Inc. to include a new medicines, Insulin Glargine, to improve patient access...
India’s biotech and pharmaceutical R&D journey began much earlier than many believe, with its foundations laid in the 1990s and early 2000s. Indian companies, inspired by global multinationals such as Pfizer, Merck, and Novartis, invested heavily in
Tamil Nadu is under the spotlight after a spate of child deaths linked to adulterated cough syrup manufactured by Sresan Pharmaceuticals. The deaths have now increased to 23, as two more children, Garvik Pawar, and Mayank Suryawanshi
According to the World Health Organisation (WHO), it is expected that a Global Medical Products Emergency Alert regarding Coldrif will be issued only after verification from Indian officials.
According to the US Food and Drug Administration (USFDA), products of Glenmark, Granules India, Sun Pharma, Zydus, and Unichem have been voluntarily recalled in the United States due to manufacturing deficiencies.
The U.S. Food and Drug Administration (FDA), with the support of the Department of Health and Human Services (HHS), has revealed strict measures, With the aim to shield consumers in a major way
, CDSCO.jpg)